<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02130427</url>
  </required_header>
  <id_info>
    <org_study_id>UPCC 08909</org_study_id>
    <nct_id>NCT02130427</nct_id>
  </id_info>
  <brief_title>A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy</brief_title>
  <official_title>A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abramson Cancer Center of the University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abramson Cancer Center of the University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study will determine changes over time in tumor volume/motion &amp; patient anatomy,
      as well as dose distributions to normal organs. The study will inform medical decision-making
      about need for (and timing of) re-calibration of radiation dosimetry plans. Weekly CT and/or
      serial MR scans will be employed for those patients receiving 7-8 wks of radiation therapy.
      The study will enroll 30 patients in each stratum: Non small cell lung cancer (NSCLC), Head &amp;
      Neck, gastrointestinal (GI) and Gynecologic tumor.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2010</start_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Diagnostic</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Adverse Events</measure>
    <time_frame>4-6 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Biopsy Proven Non Small Cell Lung Cancer</condition>
  <condition>Head and Neck Cancer</condition>
  <condition>Gastrointestinal Cancer</condition>
  <condition>Colorectal Cancer</condition>
  <condition>Rectal Cancers</condition>
  <condition>Gynecological Malignancy Requiring Definitive Radiotherapy</condition>
  <arm_group>
    <arm_group_label>NSCLC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Head &amp; Neck</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>GI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Gynecologic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiation Therapy</intervention_name>
    <arm_group_label>NSCLC</arm_group_label>
    <arm_group_label>Head &amp; Neck</arm_group_label>
    <arm_group_label>GI</arm_group_label>
    <arm_group_label>Gynecologic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 and above.

          -  Biopsy proven diagnosis of non-small cell lung cancer, small cell lung cancer, head
             and neck, esophageal, gastric, pancreatic, anal, hepatic, biliary, colorectal,
             cervical, endometrial, vaginal, vulvar, ovarian cancer and any other gastrointestinal
             or gynecological cancers requiring definitive radiotherapy alone with or without
             concurrent chemotherapy.

          -  Able to provide written informed consent and comply with all study procedures.

          -  Entire course of radiotherapy will be delivered at the University of Pennsylvania
             Perelman Center for Advanced Medicine.

        Exclusion Criteria:

        - Pregnancy or women of childbearing potential and men who are sexually active and not
        willing/able to use medically acceptable forms of contraception; this exclusion is
        necessary because the treatment involved in this study may be significantly teratogenic.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Simone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Abramson Cancer Center of the University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Abramson Cancer Center of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2014</study_first_submitted>
  <study_first_submitted_qc>May 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2014</study_first_posted>
  <last_update_submitted>September 29, 2017</last_update_submitted>
  <last_update_submitted_qc>September 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adult subjects</keyword>
  <keyword>NSCLC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

